Asia-Pacific Infusion Pumps Market – Industry Trends and Forecast to 2030

Asia-Pacific Infusion Pumps Market Size

• The Asia-Pacific infusion pumps market size was valued at USD 4.84 billion in 2024 and is expected to reach USD 7.10 billion by 2032, at a CAGR of 4.90% during the forecast period
• The market growth is largely fueled by the rising prevalence of chronic diseases, increasing demand for advanced drug delivery systems, and the growing aging population across Asia-Pacific, which collectively drive the need for infusion pumps in both hospital and home care settings. Countries such as China, India, and Japan are witnessing a surge in the adoption of infusion therapy for conditions such as diabetes, cancer, and pain management, supported by improving healthcare infrastructure and expanding access to treatment in both urban and rural regions
• Furthermore, technological advancements such as smart infusion pumps with integrated safety features, the expansion of home healthcare services, and the increasing focus on reducing medication errors are propelling market adoption. Favorable government initiatives, coupled with rising investments from international medical device manufacturers and the growth of local production capabilities, are significantly enhancing the availability, affordability, and innovation within the Asia-Pacific Infusion Pumps market

Asia-Pacific Infusion Pumps Market Analysis

• The Asia-Pacific Infusion Pumps Market is experiencing robust growth, driven by rising demand for advanced, accurate, and patient-friendly infusion delivery systems across countries such as China, India, Japan, South Korea, Australia, Thailand, Indonesia, and Vietnam.
• Factors such as increasing prevalence of chronic diseases, expanding hospital infrastructure, rising adoption of home healthcare services, and technological advancements in smart and portable infusion pumps are contributing to the market’s rapid expansion in the region
• China dominated the Asia-Pacific infusion pumps market, accounting for the largest revenue share of 38.5% in 2024, supported by its large patient pool, growing elderly population, strong domestic manufacturing capabilities, and rapid integration of AI-enabled and wireless infusion pump technologies in hospitals and specialty clinics
• India is projected to register the fastest CAGR of 12.9% in the Asia-Pacific infusion pumps market during the forecast period, driven by growing awareness of advanced drug delivery systems, increasing healthcare expenditure, and government-led initiatives to improve access to medical devices in semi-urban and rural areas
• The traditional infusion pumps segment dominated the Asia-Pacific infusion pumps market with the largest revenue share of 58.7% in 2024, driven by their widespread use in hospitals and clinics for a variety of therapies, cost-effectiveness, and strong compatibility with existing healthcare infrastructure

Report Scope and Asia-Pacific Infusion Pumps Market Segmentation

Asia-Pacific Infusion Pumps Market Trends

Growing Technological Advancements and Patient-Centric Innovations

• A significant and accelerating trend in the Asia-Pacific infusion pumps market is the increasing focus on patient safety, precision drug delivery, and user-friendly device designs. Healthcare providers in the region are placing greater emphasis on solutions that not only deliver medications accurately but also improve patient comfort and compliance during long-term treatments. This is leading to the adoption of advanced infusion systems equipped with automated flow control, built-in safety alarms, and integrated data logging for better clinical decision-making
• Major manufacturers across the region are forming strategic partnerships with hospitals, research institutions, and technology companies to develop next-generation infusion pumps. These innovations include smart sensors for real-time drug monitoring, wireless connectivity for remote supervision, and AI-powered algorithms that adjust infusion rates based on patient-specific needs. For instance, in 2023, a leading Japanese medical device manufacturer launched a cloud-enabled infusion pump that allows healthcare staff to monitor multiple patients simultaneously from a centralized dashboard—reducing nurse workload and minimizing dosing errors
• The increasing use of infusion pumps in hospitals, specialized clinics, ambulatory surgical centers, and home healthcare is further propelling market growth. These devices are proving vital in therapies such as chemotherapy, pain management, antibiotic delivery, and parenteral nutrition—particularly in aging populations and patients with chronic diseases. Healthcare facilities across Asia-Pacific are recognizing the role of infusion pumps in ensuring uninterrupted treatment, reducing hospitalization time, and improving recovery outcomes
• Academic and clinical research institutions in countries such as Japan, China, and Australia are actively conducting performance evaluations of infusion pump technologies, focusing on drug stability, delivery accuracy, and usability in diverse care environments. The findings from these studies are being used to design devices tailored to local healthcare challenges, such as rural access, multilingual user interfaces, and compatibility with regional treatment protocols
• As the Asia-Pacific region continues to invest heavily in healthcare modernization, digital health integration, and chronic disease management, the Infusion Pumps market is poised for sustained growth. Government initiatives supporting medical device innovation, rising healthcare expenditure, and the growing acceptance of remote monitoring solutions are expected to further accelerate adoption in the coming years

Asia-Pacific Infusion Pumps Market Dynamics

Driver

Growing Demand Due to Rising Health Awareness and Advanced Care Trends

• The Asia-Pacific infusion pumps market is experiencing robust growth, driven by a heightened focus on health-conscious living, advanced medical care, and precision drug delivery. Countries such as China, India, Japan, and Australia are witnessing increased adoption of infusion pumps in hospitals, specialty clinics, and home care settings due to rising incidences of chronic illnesses such as diabetes, cancer, and cardiovascular diseases.
  • For instance, in February 2024, Terumo Corporation expanded its infusion systems portfolio in Japan by launching a next-generation smart infusion pump designed for enhanced accuracy, wireless connectivity, and integration with hospital electronic medical record (EMR) systems, catering to the growing demand for connected healthcare solutions.
• The surge in aging populations and post-surgical recovery cases, along with the growing prevalence of long-term treatment protocols, has accelerated demand for portable and user-friendly infusion pumps. This trend is particularly prominent in urban healthcare centers where patient comfort, dosing precision, and safety are prioritized.
• Government-led initiatives in countries such as Australia, Singapore, and South Korea promoting digital healthcare integration and smart hospital infrastructure are encouraging manufacturers to invest in connected infusion devices with remote monitoring and real-time data analytics capabilities
• E-commerce platforms and direct hospital procurement systems are transforming market accessibility, enabling suppliers to efficiently cater to both metropolitan and regional healthcare facilities. This digital shift is also facilitating timely maintenance, training, and customization of infusion pump solutions across platforms such as Alibaba Health, Amazon Business, and dedicated B2B medical device portals

Restraint/Challenge

Barriers to Adoption in Price-Conscious and Underserved Healthcare Areas

• The relatively high acquisition cost of advanced infusion pumps, especially smart and multi-channel systems, compared to basic models, poses a challenge in price-sensitive healthcare markets in Southeast Asia and South Asia
• In rural and underserved areas, infrastructural limitations and inadequate clinical training hinder widespread adoption, as many facilities rely on older, manual infusion methods due to budget constraints
• Distribution remains a challenge in remote regions of Asia-Pacific due to underdeveloped medical supply chains and insufficient service networks, leading to delays in equipment installation, servicing, and spare parts availability
• In addition, reliance on imported components for high-end infusion systems in certain countries results in elevated production costs, making products less competitive against locally manufactured basic alternatives
• To overcome these barriers, market players are increasingly focusing on localized assembly, subsidized leasing programs for hospitals, and targeted training initiatives for rural healthcare workers, thereby expanding adoption in regions with historically low penetration rates

Asia-Pacific Infusion Pumps Market Scope

The market is segmented on the basis of type, accessories and consumable, application and End User.

• By Type

On the basis of type, the Asia-Pacific infusion pumps market is segmented into traditional infusion pumps and specialty infusion pumps. The traditional infusion pumps segment dominated the market with the largest revenue share of 58.7% in 2024, driven by their widespread use in hospitals and clinics for a variety of therapies, cost-effectiveness, and strong compatibility with existing healthcare infrastructure.

The specialty infusion pumps segment is projected to grow at the fastest CAGR of 9.4% from 2025 to 2032, supported by the rising prevalence of chronic diseases such as diabetes and cancer, along with the increasing adoption of insulin pumps and implantable pumps for targeted therapy.

• By Accessories and Consumables

On the basis of accessories and consumables, the market is segmented into volumetric infusion pumps, insulin pumps, enteral infusion pumps, syringe infusion pumps, ambulatory infusion pumps, PCA pumps, implantable infusion pumps, infusion catheters, IV/administration sets, needleless connectors, cannulas, tubing and extension sets, valves, and others. The volumetric infusion pumps segment led the market with a share of 26.3% in 2024, due to their high precision in fluid delivery and extensive usage across oncology, critical care, and surgery.

The insulin pumps segment is expected to record the highest CAGR of 10.8% from 2025 to 2032, fueled by the rising diabetic population, growing patient awareness, and increasing adoption of continuous glucose monitoring (CGM)-integrated pumps.

• By Application

On the basis of application, the Asia-Pacific Infusion Pumps market is segmented into chemotherapy/oncology, diabetes, gastroenterology, analgesia/pain management, paediatrics/neonatology, haematology, and others. The chemotherapy/oncology segment dominated with a market share of 33.5% in 2024, driven by the growing incidence of cancer, expansion of oncology treatment centers, and increasing demand for precise drug delivery systems.

The diabetes segment is anticipated to grow at the fastest CAGR of 11.2% from 2025 to 2032, supported by technological advancements in insulin pump design, government initiatives to combat diabetes, and increased patient preference for wearable and portable devices.

• By End User

On the basis of end user, the market is segmented into hospitals, home care settings, ambulatory care settings, and academic & research institutes. The hospitals segment accounted for the largest market share of 49.8% in 2024, owing to the availability of advanced infusion systems, higher patient admission rates, and the presence of trained healthcare professionals.

The home care settings segment is projected to witness the highest CAGR of 9.9% from 2025 to 2032, driven by the shift toward outpatient care, increasing demand for self-administration devices, and the growth of remote patient monitoring solutions.

Asia-Pacific Infusion Pumps Market Regional Analysis

• Asia-Pacific held a market share of 32.8% in the global infusion pumps market, in 2024, driven by the region’s large patient population, rising prevalence of chronic diseases such as diabetes and cancer, and increasing adoption of advanced infusion technologies in hospitals and home healthcare settings
• Growing investments in healthcare infrastructure, coupled with government initiatives to improve access to advanced medical devices in both urban and rural areas, have further contributed to the region’s market leadership
• The market is supported by strong domestic manufacturing capabilities in countries such as China, India, and Japan, along with expanding distribution networks and increasing penetration of international infusion pump brands. Rapid advancements in portable and smart infusion systems, along with a rise in medical tourism, are also boosting growth across the region

China Asia-Pacific Infusion Pumps Market Insight

The China infusion pumps market held the largest market share in the Asia-Pacific infusion pumps market at 38.5% in 2024, supported by its rapidly expanding healthcare infrastructure, growing elderly population, and increasing demand for precision drug delivery systems in critical care and oncology. The country benefits from a robust domestic manufacturing base, competitive pricing, and a well-established hospital procurement network. In addition, rising adoption of ambulatory infusion pumps in homecare settings, supported by favorable reimbursement policies, continues to strengthen China’s position as the regional leader.

India Asia-Pacific Infusion Pumps Market Insight

The India infusion pumps market is projected to register the fastest CAGR of 12.9% from 2025 to 2032, driven by growing healthcare expenditure, increased diagnosis and treatment rates for chronic and acute illnesses, and government programs aimed at modernizing medical facilities in tier 2 and tier 3 cities. The rapid expansion of private hospitals, the entry of global infusion pump manufacturers through partnerships, and growing adoption of cost-effective, portable infusion devices in home healthcare are fueling the country’s strong growth trajectory.

Asia-Pacific Infusion Pumps Market Share

The Asia-Pacific infusion pumps industry is primarily led by well-established companies, including:

• BD (U.S.)
• B. Braun SE (Germany)
• Baxter (U.S.)
• Fresenius Kabi AG (Germany)
• ICU Medical, Inc. (U.S.)
• Smiths Group PLC (U.K.)
• Medtronic (U.S.)
• Moog Inc. (U.S.)
• Terumo Corporation (Japan)
• Avanos Corporate (U.S.)
• NIPRO (Japan)
• Insulet Corporation (U.S.)
• Tandem Diabetes Care, Inc. (U.S.)
• JMS Co. Ltd. (Japan)
• F. Hoffmann-La Roche Ltd. (Switzerland)

Latest Developments in Asia-Pacific Infusion Pumps market

• In July 2025, The U.S. Food and Drug Administration (FDA) announced a Class I recall of Baxter's Spectrum infusion pump models due to missing motor mounting screws. This defect could lead to therapy interruption, underinfusion, or overinfusion, posing serious health risks. Baxter has reported one serious injury linked to this issue
• In June 2025, The FDA shared that Baxter updated the usage instructions for the Novum IQ large-volume infusion pump (LVP) following reports of flow rate variability, especially after prolonged standby mode. In severe cases, underinfusion of up to 50% was observed. This prompted an urgent correction, with healthcare providers advised to adhere to updated protocols to prevent under- or over-infusion
• In January 2022, ICU Medical Inc. declared that the purchase of Smiths Medical from Smiths Group plc had been completed. Syringe and ambulatory infusion devices, vascular access, and essential care products are all part of the Smiths Medical business. The combined businesses, when combined with ICU Medical's current businesses, create a market-leading infusion therapy company with pro forma combined revenues of about USD 2.5 billion

SKU-1560